A detailed history of Sam Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Sam Advisors, LLC holds 11,695 shares of JNJ stock, worth $1.71 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
11,695
Previous 11,838 1.21%
Holding current value
$1.71 Million
Previous $1.73 Million 9.54%
% of portfolio
0.7%
Previous 0.64%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$145.48 - $167.38 $20,803 - $23,935
-143 Reduced 1.21%
11,695 $1.9 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $13,571 - $14,831
-94 Reduced 0.79%
11,838 $1.73 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $50,291 - $52,727
-324 Reduced 2.64%
11,932 $1.89 Million
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $343,907 - $375,274
-2,362 Reduced 16.16%
12,256 $1.92 Million
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $401,835 - $450,158
-2,580 Reduced 15.0%
14,618 $2.28 Million
Q2 2023

Jul 25, 2023

BUY
$154.35 - $166.11 $147,404 - $158,635
955 Added 5.88%
17,198 $2.85 Million
Q1 2023

Apr 28, 2023

SELL
$151.05 - $180.26 $87,911 - $104,911
-582 Reduced 3.46%
16,243 $2.52 Million
Q4 2022

Jan 18, 2023

BUY
$160.2 - $179.79 $28,034 - $31,463
175 Added 1.05%
16,825 $2.97 Million
Q3 2022

Oct 25, 2022

SELL
$161.33 - $179.52 $126,321 - $140,564
-783 Reduced 4.49%
16,650 $2.72 Million
Q2 2022

Jul 12, 2022

SELL
$168.19 - $186.01 $119,078 - $131,695
-708 Reduced 3.9%
17,433 $3.1 Million
Q1 2022

Apr 05, 2022

BUY
$158.14 - $179.59 $94,883 - $107,754
600 Added 3.42%
18,141 $3.22 Million
Q4 2021

Jan 11, 2022

BUY
$155.93 - $173.01 $312,951 - $347,231
2,007 Added 12.92%
17,541 $3.04 Million
Q3 2021

Oct 01, 2021

BUY
$161.5 - $179.47 $2.51 Million - $2.79 Million
15,534 New
15,534 $2.51 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sam Advisors, LLC Portfolio

Follow Sam Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sam Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sam Advisors, LLC with notifications on news.